| Life Care Center Of Littleton | |
| 1500 W Mineral Ave, Littleton, Colorado 80120 | |
| (303) 795-7300 | |
| Name | Life Care Center Of Littleton |
|---|---|
| Location | 1500 W Mineral Ave, Littleton, Colorado |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 57.83% |
| Medicare ID (CCN) | 065370 |
| Legal Business Name | Arapahoe Ltc Investors, Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1306854013 |
| Organization Name | ARAPAHOE LTC INVESTORS, LLC |
| Doing Business As | LIFE CARE CENTER OF LITTLETON |
| Address | 1500 W Mineral Ave, Littleton, CO 80120 |
| Phone Number | 303-795-7300 |
News Archive
New research led by Nadia R. Roan of Gladstone Institutes and the University of California, San Francisco, finds a correlation between high numbers of inflammatory CXCR4+ T cells and regulatory T cells specific to SARS-CoV-2 and dying from infection. In contrast, people who recovered from severe COVID-19 illness were more likely to have many SARS-CoV-2-specific T cells that perform homeostatic proliferation.
Diagnostic Imaging International Corp. announced today that its wholly-owned subsidiary, Canadian Teleradiology Services ("CTS"), has entered into a new agreement to provide Teleradiology services to a hospital in south-western Ontario.
Schering-Plough Corporation today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma. The investigational Grass AIT treatment is designed to work by inducing a protective immune response against grass pollen allergy and providing sustained prevention of allergy symptoms, treating both the symptoms and the underlying cause of the disease.
Massachusetts General Hospital Cancer Center researchers have discovered a previously unknown feature of common tumor cells - massive overexpression of certain DNA sequences that do not code for proteins.
Researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered a new gene fusion that is highly expressed in a subset of prostate cancers.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
New research led by Nadia R. Roan of Gladstone Institutes and the University of California, San Francisco, finds a correlation between high numbers of inflammatory CXCR4+ T cells and regulatory T cells specific to SARS-CoV-2 and dying from infection. In contrast, people who recovered from severe COVID-19 illness were more likely to have many SARS-CoV-2-specific T cells that perform homeostatic proliferation.
Diagnostic Imaging International Corp. announced today that its wholly-owned subsidiary, Canadian Teleradiology Services ("CTS"), has entered into a new agreement to provide Teleradiology services to a hospital in south-western Ontario.
Schering-Plough Corporation today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma. The investigational Grass AIT treatment is designed to work by inducing a protective immune response against grass pollen allergy and providing sustained prevention of allergy symptoms, treating both the symptoms and the underlying cause of the disease.
Massachusetts General Hospital Cancer Center researchers have discovered a previously unknown feature of common tumor cells - massive overexpression of certain DNA sequences that do not code for proteins.
Researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered a new gene fusion that is highly expressed in a subset of prostate cancers.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.79 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.69 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 58.62 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.55 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.8 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.89 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.04 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.79 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.81 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.46 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.84 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 29.03 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.09 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.87 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.6 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 81.16 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.14 | 82.93 |
News Archive
New research led by Nadia R. Roan of Gladstone Institutes and the University of California, San Francisco, finds a correlation between high numbers of inflammatory CXCR4+ T cells and regulatory T cells specific to SARS-CoV-2 and dying from infection. In contrast, people who recovered from severe COVID-19 illness were more likely to have many SARS-CoV-2-specific T cells that perform homeostatic proliferation.
Diagnostic Imaging International Corp. announced today that its wholly-owned subsidiary, Canadian Teleradiology Services ("CTS"), has entered into a new agreement to provide Teleradiology services to a hospital in south-western Ontario.
Schering-Plough Corporation today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma. The investigational Grass AIT treatment is designed to work by inducing a protective immune response against grass pollen allergy and providing sustained prevention of allergy symptoms, treating both the symptoms and the underlying cause of the disease.
Massachusetts General Hospital Cancer Center researchers have discovered a previously unknown feature of common tumor cells - massive overexpression of certain DNA sequences that do not code for proteins.
Researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered a new gene fusion that is highly expressed in a subset of prostate cancers.
› Verified 5 days ago
Cherrelyn Healthcare Center Location: 5555 S Elati St, Littleton, Colorado 80120 Phone: (303) 798-8686 | |
Orchard Park Health Care Center Location: 6005 S Holly St, Littleton, Colorado 80121 Phone: (303) 773-1000 | |
Littleton Care And Rehabilitation Center Location: 5822 S Lowell Way, Littleton, Colorado 80123 Phone: (303) 798-2497 | |
Life Care Center Of Littleton Location: 1500 W Mineral Ave, Littleton, Colorado 80120 Phone: (303) 795-7300 | |